Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

106.49
-1.3000-1.21%
Volume:1.01M
Turnover:108.82M
Market Cap:9.39B
PE:-52.98
High:110.00
Open:108.85
Low:105.71
Close:107.79
52wk High:110.18
52wk Low:14.51
Shares:88.17M
Float Shares:80.98M
Volume Ratio:1.19
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:9.83
PE(LYR):-53.91

Loading ...

Spyre Therapeutics CMO Sheldon Sloan disposes of common shares worth $3.69 million

Reuters
·
May 02

Spyre CEO Cameron Turtle sells $1.05 million common shares

Reuters
·
May 02

Spyre Therapeutics grants stock options for 20,800 shares under inducement plan

Reuters
·
May 02

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire
·
May 02

Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), Spyre Therapeutics (SYRE) and Regeneron (REGN)

TIPRANKS
·
Apr 30

How Investors May Respond To Spyre Therapeutics (SYRE) Upsized Equity Raise After Positive SPY001 Phase 2 Data

Simply Wall St.
·
Apr 27

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE) and Revolution Medicines (RVMD)

TIPRANKS
·
Apr 20

Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Spyre Therapeutics (SYRE)

TIPRANKS
·
Apr 18

Spyre Therapeutics closes follow-on offering, raises USD 463.5 million

Reuters
·
Apr 17

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

BUZZ-Spyre Therapeutics gains after boosted $403 mln stock sale

Reuters
·
Apr 15

Spyre Therapeutics Prices Upsized $403 Million Share Offering

MT Newswires Live
·
Apr 15

BRIEF-Spyre Therapeutics Announces Pricing Of Upsized $403 Million Public Offering Of Common Stock

Reuters
·
Apr 15

Spyre Therapeutics Inc - Prices Public Offering of 6.5 Mln Shares at $62.00 per Share

THOMSON REUTERS
·
Apr 15

Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock

THOMSON REUTERS
·
Apr 15

Assessing Spyre Therapeutics (SYRE) Valuation After Recent Share Price Momentum And Premium P/B Multiple

Simply Wall St.
·
Apr 15

Stock Track | Spyre Therapeutics Soars 6.99% in Pre-Market on Multiple Analyst Target Price Hikes

Stock Track
·
Apr 14

Spyre Therapeutics Inc : Wedbush Raises Target Price to $80 From $65

THOMSON REUTERS
·
Apr 14

Spyre Therapeutics, Inc. : Wells Fargo Raises Target Price to $90 From $50

THOMSON REUTERS
·
Apr 14